GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.3939
-0.0450 (-10.25%)
At close: May 15, 2026, 4:00 PM EDT
0.3941
+0.0002 (0.05%)
After-hours: May 15, 2026, 7:56 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $12.43 million as of May 15, 2026. Its market cap has increased by 125.98% in one year.
Market Cap
12.43M
Enterprise Value
3.51M
1-Year Change
125.98%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $12.43M, a decrease of -85.06%. That is a compound annual growth rate of -20.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 14.20M | 71.08% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexaria Bioscience | 15.14M |
| Genenta Science | 14.86M |
| Theriva Biologics | 14.73M |
| Cellectar Biosciences | 13.57M |
| Vyome Holdings | 13.48M |
| BioLineRx | 13.46M |
| Cyclerion Therapeutics | 13.06M |
| Phio Pharmaceuticals | 13.01M |